Oncology Institute, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report2 of 6 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+28.46%
vs ±13.5% implied · ×2.11
shaded = implied · ▲▼ = realized
No thesis.
Starling Oncology, Inc.
6.55
—
No N-PORT holders.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $25.8M | 11.03% | +7.54% | |
| 2 | Deerfield ManagementDeerfield | $18.2M | 7.80% | 0.00% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $17.7M | 7.58% | −6.08% | |
| 4 | Josh Arnold Investment ConsultantJosh Arnold Investment Consultant | $13.4M | 5.72% | 0.00% | |
| 5 | Geode Capital ManagementGeodeindex-like | $10.3M | 4.41% | +8.09% | |
| 6 | Citadel AdvisorsCitadel | $9.4M | 4.04% | −26.20% | |
| 7 | Goldman Sachs GroupGoldman Sachs | $9.4M | 4.03% | +28.36% | |
| 8 | Wexford CapitalWexford Capital | $9.3M | 3.97% | 0.00% | |
| 9 | Susquehanna International GroupSusquehanna International | $8.7M | 3.74% | +121.46% | |
| 10 | State StreetState Streetindex-like | $8.4M | 3.61% | +6.26% | |
| 11 | NuveenNuveenindex-like | $7.6M | 3.27% | +1378.75% | |
| 12 | Renaissance TechnologiesRenaissance Technologies | $7.4M | 3.17% | +51.30% | |
| 13 | Jane Street GroupJane Street | $7.3M | 3.14% | +114.83% | |
| 14 | CenterBook PartnersCenterBook Partners | $6.7M | 2.88% | −20.83% | |
| 15 | Marshall WaceMarshall Wace | $6.6M | 2.84% | +257.18% | |
| 16 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $5.5M | 2.34% | +16.71% | |
| 17 | B. Riley FinancialB. Riley Financial | $4.0M | 1.72% | −20.13% | |
| 18 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $3.9M | 1.65% | +69.49% | |
| 19 | Two Sigma InvestmentsTwo Sigma | $3.6M | 1.55% | +117.33% | |
| 20 | Northern TrustNorthern Trustindex-like | $3.2M | 1.37% | +5.92% | |
| 21 | Acadian Asset ManagementAcadian | $3.1M | 1.32% | new | |
| 22 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $2.7M | 1.17% | +3.93% | |
| 23 | FourWorld Capital ManagementFourWorld | $2.7M | 1.16% | 0.00% | |
| 24 | Manatuck Hill PartnersManatuck Hill Partners | $2.4M | 1.05% | new | |
| 25 | Walleye CapitalWalleye Capital | $2.4M | 1.04% | new |
120 managers report $233.8M of Starling Oncology on form 13F for the quarter ended Jun 30 '26. 21 of them hold 80% of it; BlackRock is largest at 11.03%.
Linked news
NewsExpected move
No implied move.